Carcinogenicity of fi-Propiolactone
1961

Carcinogenicity and Reactivity of Beta-Propiolactone

Sample size: 70 publication Evidence: moderate

Author Information

Author(s): C. E. Searle

Primary Institution: Cancer Research Laboratories, Department of Pathology, The Medical School, Birmingham

Hypothesis

Is beta-propiolactone a carcinogen for humans?

Conclusion

Beta-propiolactone can cause skin tumors in mice, indicating potential carcinogenicity.

Supporting Evidence

  • Beta-propiolactone caused papillomas and squamous cell carcinomas in mice.
  • 3-bromopropionic acid showed no evidence of carcinogenicity.
  • The reaction of beta-propiolactone with cysteine was rapid and irreversible.
  • Interactions with cystine were suggested by changes in polarographic measurements.

Takeaway

This study found that a chemical called beta-propiolactone can make mice develop skin tumors, which might mean it could be harmful to humans too.

Methodology

Mice were treated with beta-propiolactone and 3-bromopropionic acid to observe tumor development.

Limitations

The study was limited to mouse models, which may not fully represent human responses.

Participant Demographics

Inbred stock albino mice and guinea pigs were used in the experiments.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication